Sirona Biochem Corp Stock Current Valuation
| SBM Stock | CAD 0.07 0.01 13.33% |
Valuation analysis of Sirona Biochem Corp helps investors to measure Sirona Biochem's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Sirona Biochem's Cash is fairly stable compared to the past year. Total Cash From Financing Activities is likely to climb to about 1.9 M in 2024, whereas Total Cashflows From Investing Activities is likely to drop (56.7 K) in 2024. Fundamental drivers impacting Sirona Biochem's valuation include:
Price Book 41.6366 | Enterprise Value 20.1 M | Enterprise Value Ebitda (7.92) | Price Sales 456.2159 | Enterprise Value Revenue 447.502 |
Overvalued
Today
Please note that Sirona Biochem's price fluctuation is out of control at this time. Calculation of the real value of Sirona Biochem Corp is based on 3 months time horizon. Increasing Sirona Biochem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sirona stock is determined by what a typical buyer is willing to pay for full or partial control of Sirona Biochem Corp. Since Sirona Biochem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sirona Stock. However, Sirona Biochem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.065 | Real 0.0578 | Hype 0.07 | Naive 0.0526 |
The intrinsic value of Sirona Biochem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sirona Biochem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sirona Biochem Corp helps investors to forecast how Sirona stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sirona Biochem more accurately as focusing exclusively on Sirona Biochem's fundamentals will not take into account other important factors: Sirona Biochem Corp Company Current Valuation Analysis
Sirona Biochem's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sirona Biochem Current Valuation | 20.11 M |
Most of Sirona Biochem's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sirona Biochem Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sirona Biochem Corp has a Current Valuation of 20.11 M. This is 99.86% lower than that of the Biotechnology sector and 99.57% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.88% higher than that of the company.
Sirona Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sirona Biochem's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sirona Biochem could also be used in its relative valuation, which is a method of valuing Sirona Biochem by comparing valuation metrics of similar companies.Sirona Biochem is currently under evaluation in current valuation category among its peers.
Sirona Fundamentals
| Return On Equity | -98.1 | ||||
| Return On Asset | -1.48 | ||||
| Operating Margin | (258.82) % | ||||
| Current Valuation | 20.11 M | ||||
| Shares Outstanding | 258.84 M | ||||
| Shares Owned By Insiders | 10.53 % | ||||
| Number Of Shares Shorted | 93.61 K | ||||
| Price To Book | 41.64 X | ||||
| Price To Sales | 456.22 X | ||||
| Revenue | 34.78 K | ||||
| Gross Profit | 621.75 K | ||||
| EBITDA | (2.26 M) | ||||
| Net Income | (2.54 M) | ||||
| Cash And Equivalents | 376.43 K | ||||
| Total Debt | 637.65 K | ||||
| Debt To Equity | 470.90 % | ||||
| Current Ratio | 0.98 X | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (1.76 M) | ||||
| Short Ratio | 1.51 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.73 | ||||
| Beta | -0.02 | ||||
| Market Capitalization | 16.82 M | ||||
| Total Asset | 1.03 M | ||||
| Retained Earnings | (43.9 M) | ||||
| Working Capital | (843.55 K) | ||||
| Net Asset | 1.03 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.